Company profile
Lipozyt Marker company profile
Lipozyt Marker provides oral anti-diabetic therapy. They offer a test kit that conducts mRNA analysis of the subcutaneous fatty tissue in combination with classic blood tests to determine individual causes of diabetes.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2014-01-01, Year
Headquarters
- Headquarters
- Dankerath, Rheinland-Pfalz, Germany
- Postal code
- 28357
- Country code
- DE
- Continent
- Europe